Author

L. Niederstadt

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:imaging· 1 Research Focus:protein folding & dynamics· 1

Frequent Co-Authors

C. Groetzinger· 3 shared A. Wagener· 2 shared J. L. von Hacht· 2 shared N. Beindorff· 2 shared S. Erdmann· 2 shared S. Exner· 2 shared S. Prasad· 2 shared W. Brenner· 2 shared

Activity by Year

2019-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

C. Groetzinger

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Secretin receptor as a target in gastrointestinal cancer: expression analysis and ligand development

A. Klussmeier, S. Aurich, L. Niederstadt, B. Wiedenmann, C. Groetzinger

This study analyzes SCTR expression in cancers and identifies key residues for secretin binding and activation, aiming to develop stable analogs for imaging and therapy.

bioRxiv · Jan 31, 2022Cancer Biology

Increasing molar activity by HPLC purification improves 68Ga-DOTA-NAPamide tumor accumulation in a B16/F1 melanoma xenograft model

J. L. von Hacht, S. Erdmann, L. Niederstadt, S. Prasad, A. Wagener, S. Exner, N. Beindorff, W. Brenner, C. Groetzinger

This study shows that HPLC purification of 68Ga-DOTA-NAPamide increases tumor uptake in B16/F1 melanoma xenografts by removing unlabeled peptide, enhancing molar activity and specific binding.

bioRxiv · Jan 31, 2019Cancer Biology

CMKLR1-targeting peptide tracers for PET/MR imaging of breast cancer

S. Erdmann, L. Niederstadt, E. J. Koziolek, J. D. Castillo Gomez, S. Prasad, A. Wagener, J. L. von Hacht, S. Hallmann, S. Exner, S. Bandholtz, N. Beindorff, W. Brenner, C. Groetzinger

This paper develops CMKLR1-targeting peptide tracers for PET/MR imaging of breast cancer, showing high specificity and affinity in vivo.

Theranostics · Jan 1, 2019Peer-reviewedCancer Biology